Clinical Trial Update: Efficacy and Safety of ACH24 in the Treatment of Vitiligo [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ACH24 for vitiligo has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• ACH24

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Vitiligo | Phase 3 | Status: WITHDRAWN